Stereotactic Radiosurgery for Recurrent or Unresectable Pilocytic Astrocytoma
Christopher L. Hallemeier(Mayo Clinic in Arizona), Scott L. Stafford(Mayo Clinic in Arizona), Bruce E. Pollock(Mayo Clinic), P.D. Brown(The University of Texas MD Anderson Cancer Center), Michael J. Link(Mayo Clinic), Paula J. Schomberg(WinnMed)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2011
Cited by 2
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Oesophageal cancer
|The Lancet|2024|265